Sort
261,768 grants matching “gene therapy”
Comparative Modeling: Informing Breast Cancer Control Practice & Policy
$1,352,685Jeanne Mandelblatt · Georgetown University · U01 · FY2011 · CA
ASPirin in Reducing Events in the Elderly
$1,352,658Richard H Grimm · Hennepin Healthcare Research Institute · U01 · FY2013 · AG
Genetic and Environmental Modifiers Of Autoimmune Disease
$1,352,514Silvia Bolland · National Institute Of Allergy And Infectious Diseases · ZIA · FY2013 · AI
Gene Therapy for SCID-X1 using a self-inactivating (SIN) gammaretroviral vector
$1,352,430David A Williams · Boston Children'S Hospital · U01 · FY2010 · AI
Ion Channels and Membrane Receptors in Pulmonary Arterial Hypertension
$1,352,400Jason X.-J. Yuan · University Of Florida · R35 · FY2025 · HL
Protein Expression Facility
$1,352,350Robert Petrovich · National Institute Of Environmental Health Sciences · ZIC · FY2022 · ES
NADPH Oxidases as Novel Targets for Cancer Therapy
$1,352,059James Doroshow · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA
IGNITE Cost Extension - Admin Supplement
$1,351,790Larisa Humma Cavallari · University Of Florida · U01 · FY2023 · HG
Functionally Defining HIV-Host Interactions During the Early HIV-1 Lifecycle
$1,351,668Thomas Hope · Northwestern University At Chicago · R01 · FY2023 · AI
Papillomavirus Virion Proteins and Vaccines
$1,351,543John T. Schiller · Division Of Basic Sciences - Nci · Z01 · FY2008 · CA
A Pilot Trial of the effect of Vorinostat and AGS-004 on Persistent HIV-1 Infection
$1,351,542David M. Margolis · Univ Of North Carolina Chapel Hill · U01 · FY2017 · AI
MPD Clinical Consortium
$1,351,456Lewis Silverman · Icahn School Of Medicine At Mount Sinai · P01 · FY2008 · CA
Novel diagnostics and therapeutics for caliciviruses
$1,351,395Baylor College Of Medicine · P01 · FY2005 · AI
MICROSCALED PROTEOGENOMICS FOR CANCER CLINICAL TRIALS
$1,351,343Matthew J Ellis · Baylor College Of Medicine · U01 · FY2019 · CA
In vivo Pathway Discovery in Autosomal Dominant Polycystic Kidney Disease
$1,351,314Stefan Somlo · Yale University · RC2 · FY2019 · DK
PREQUEL Study In PRE-manifest HD of CoQ10/UbiquinonE Leading to Preventive Trials
$1,351,314Christopher A Ross · Johns Hopkins University · R01 · FY2009 · NS
Molecular Mechanisms of Fate Choice in Neural Stem Cells
$1,351,294Charles Stiles · Dana-Farber Cancer Inst · P01 · FY2008 · NS
Definitive Preclinical Studies of Hydrolase Gene Transfer to Treat Cocaine Abuse
$1,351,080Kah-Whye Peng · Mayo Clinic Rochester · UH3 · FY2019 · DA
Targeting PTEN Null Tumors via Inhibition of the p110beta Isoform of PI3 Kinase
$1,350,835Thomas M Roberts · Dana-Farber Cancer Inst · RC2 · FY2010 · CA
Customized stem cells for clinical application in blood disorders
$1,350,804George Q Daley · Boston Children'S Hospital · R24 · FY2017 · DK
Inhibition Of Renal Injury
$1,350,803Robert A Star · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2024 · DK
Production of Pedigreed SPF Rhesus Macaques
$1,350,754Nicholas W Lerche · University Of California At Davis · U42 · FY2007 · RR
Molecular Gene and Radiation Therapies for Cancer
$1,350,392Svend O Freytag · Henry Ford Health System · P01 · FY2008 · CA
Immunopathogenesis of Adenovirus Keratitis
$1,350,351James Chodosh · Massachusetts Eye And Ear Infirmary · R01 · FY2009 · EY
Claude D. Pepper Older Americans Independence Center (P30 Clinical Trial Optional)
$1,350,157George A Kuchel · University Of Connecticut Sch Of Med/Dnt · P30 · FY2023 · AG